Michael R. Jeune

623 total citations
10 papers, 284 citations indexed

About

Michael R. Jeune is a scholar working on Surgery, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Michael R. Jeune has authored 10 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 2 papers in Organic Chemistry and 2 papers in Molecular Biology. Recurrent topics in Michael R. Jeune's work include Protease and Inhibitor Mechanisms (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Calcium signaling and nucleotide metabolism (2 papers). Michael R. Jeune is often cited by papers focused on Protease and Inhibitor Mechanisms (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Calcium signaling and nucleotide metabolism (2 papers). Michael R. Jeune collaborates with scholars based in United States and Switzerland. Michael R. Jeune's co-authors include Margaret F. Prescott, Wilbur K. Sawyer, Shari L. Caplan, Arco Y. Jeng, Mary Chou, John C. Ulrich, Barry G. Shearer, Todd Shearer, Robert W. Wiethe and Thomas B. Stanley and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Atherosclerosis.

In The Last Decade

Michael R. Jeune

9 papers receiving 268 citations

Peers

Countries citing papers authored by Michael R. Jeune

Since Specialization

Citations

This map shows the geographic impact of Michael R. Jeune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Jeune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Jeune more than expected).

Fields of papers citing papers by Michael R. Jeune

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Jeune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Jeune. The network helps show where Michael R. Jeune may publish in the future.

Co-authorship network of co-authors of Michael R. Jeune

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Jeune. A scholar is included among the top collaborators of Michael R. Jeune based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Jeune. Michael R. Jeune is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	2,4-Diamino-8-quinazoline carboxamides as novel, potent inhibitors of the NAD hydrolyzing enzyme CD38: Exploration of the 2-position structure-activity relationships 2018 ·Bioorganic & Medicinal Chemistry ·David N. Deaton, Curt D. Haffner, Brad R. Henke, Michael R. Jeune, Barry G. Shearer, Eugene L. Stewart, J. Darren Stuart, John C. Ulrich	12
2	Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38 2015 ·Journal of Medicinal Chemistry ·J. David Becherer, Eric E. Boros, Tiffany Carpenter, David J. Cowan, David N. Deaton, Curt D. Haffner, Michael R. Jeune, István Káldor, (unknown), Frank Preugschat, Tara Rheault, (unknown), Barry G. Shearer, Todd Shearer, Lisa M. Shewchuk, Terrence L. Smalley, Eugene L. Stewart, J. Darren Stuart, John C. Ulrich	44
3	Identification and Characterization of 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist 2010 ·Journal of Medicinal Chemistry ·Barry G. Shearer, Robert W. Wiethe, (unknown), Andrew N. Billin, James M. Way, Thomas B. Stanley, Craig D. Wagner, Robert X. Xu, Lisa M. Leesnitzer, Raymond V. Merrihew, Todd Shearer, Michael R. Jeune, John C. Ulrich, Timothy M. Willson	61
4	CGP 43371 paradoxically inhibits development of rabbit atherosclerotic lesions while inducing extra-arterial foam cell formation 2001 ·Atherosclerosis ·David L. Feldman, Wilbur K. Sawyer, Michael R. Jeune, (unknown), (unknown), Margaret F. Prescott	2
5	The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881 1999 ·Atherosclerosis ·David L. Feldman, (unknown), (unknown), Wilbur K. Sawyer, Michael R. Jeune, (unknown), (unknown), Margaret F. Prescott	6
6	Enhanced Expression of Matrix Metalloproteinase‐3, ‐12, and ‐13 mRNAs in the Aortas of Apolipoprotein E‐deficient Mice with Advanced Atherosclerosis 1999 ·Annals of the New York Academy of Sciences ·Arco Y. Jeng, Mary Chou, Wilbur K. Sawyer, Shari L. Caplan, (unknown), Michael R. Jeune, Margaret F. Prescott	29
7	Effect of Matrix Metalloproteinase Inhibition on Progression of Atherosclerosis and Aneurysm in LDL Receptor‐Deficient Mice Overexpressing MMP‐3, MMP‐12, and MMP‐13 and on Restenosis in Rats after Balloon Injury 1999 ·Annals of the New York Academy of Sciences ·Margaret F. Prescott, Wilbur K. Sawyer, (unknown), Michael R. Jeune, Mary Chou, Shari L. Caplan, Arco Y. Jeng	113
8	[CLINICAL STUDY OF THE ACTION OF A HISTIDINE DECARBOXYLASE INHIBITOR (554-L) IN ALLERGIC DISEASES IN CHILDREN]. 1996 ·PubMed ·Michael R. Jeune, Rosalı́a Carrón, G. Humbert	0
9	[Abdominal aorta aneurysm during Bourneville's tuberous sclerosis]. 1971 ·PubMed ·F Freyçon, P Mollard, (unknown), (unknown), J. P. Chazalette, (unknown), (unknown), Michael R. Jeune	16
10	The tryptophan load test for detecting vitamin B6 deficiency in children. 1959 ·Michael R. Jeune, J Cotte, M Hermier, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact